Eleven Therapeutics vs Lembas Bio
Eleven Therapeutics vs Lembas Bio, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Eleven Therapeutics is on 56/100 and Lembas Bio on 46/100.
Where each one leads
Eleven Therapeutics
- our overall score: 56/100 against 46/100
- domain rating: 13/100 against 10/100
- headcount: 28 against 12
- LinkedIn following: 5,528 against 1,232
Lembas Bio
- agent readiness: 48/100 against 40/100
At a glance
| Measure | Eleven Therapeutics | Lembas Bio |
|---|---|---|
| What it is | Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases. | Developing novel therapeutics for rare genetic diseases. |
| Category | Healthcare, Life Sciences, Therapeutics, Biotech | Life Sciences, Biotech, Drug Discovery, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2017 | 2023 |
| Headquarters | London, United Kingdom | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Eleven Therapeutics | Lembas Bio |
|---|---|---|
| Employees | 28 | 12 |
| Headcount growthLast 12 months | +17.6% | Not published |
| Open roles | 4 | Not published |
| Total funding | $22.0M | Not published |
| Latest round | Seed | Not published |
| LinkedIn followers | 5,528 | 1,232 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Eleven Therapeutics | Lembas Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 46/100 |
| Traction | 51/100 | 11/100 |
| Team | 70/100 | 60/100 |
| Search visibility | 30/100 | 37/100 |
| Quality | 58/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | D (48/100) |
| Domain ratingLink authority, 0-100 | 13/100 | 10/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Eleven Therapeutics | Lembas Bio |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | Webflow | Wix |
Eleven Therapeutics vs Lembas Bio: common questions
Which is better, Eleven Therapeutics or Lembas Bio?
On our 0-100 score Eleven Therapeutics rates higher (56/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Eleven Therapeutics and Lembas Bio compare on the numbers?
Eleven Therapeutics leads on our overall score (56/100 against 46/100), domain rating (13/100 against 10/100), headcount (28 against 12), LinkedIn following (5,528 against 1,232). Lembas Bio leads on agent readiness (48/100 against 40/100).
Read the full Eleven Therapeutics review and pricing or the Lembas Bio review and pricing. You can also browse other Eleven Therapeutics alternatives we track.